IDEAYA Biosciences (IDYA) Consolidated Net Income: 2020-2025
Historic Consolidated Net Income for IDEAYA Biosciences (IDYA) over the last 4 years, with Sep 2025 value amounting to $108.5 million.
- IDEAYA Biosciences' Consolidated Net Income rose 262.13% to $108.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$167.5 million, marking a year-over-year increase of 25.47%. This contributed to the annual value of -$327.0 million for FY2024, which is 143.23% down from last year.
- IDEAYA Biosciences' Consolidated Net Income amounted to $108.5 million in Q3 2025, which was up 175.24% from -$144.1 million recorded in Q4 2024.
- Over the past 5 years, IDEAYA Biosciences' Consolidated Net Income peaked at $108.5 million during Q3 2025, and registered a low of -$144.1 million during Q4 2024.
- For the 3-year period, IDEAYA Biosciences' Consolidated Net Income averaged around -$39.2 million, with its median value being -$41.9 million (2023).
- As far as peak fluctuations go, IDEAYA Biosciences' Consolidated Net Income slumped by 5,179.70% in 2023, and later surged by 262.13% in 2025.
- IDEAYA Biosciences' Consolidated Net Income (Quarterly) stood at -$18.4 million in 2021, then slumped by 43.95% to -$26.4 million in 2022, then crashed by 58.52% to -$41.9 million in 2023, then slumped by 243.87% to -$144.1 million in 2024, then surged by 262.13% to $108.5 million in 2025.
- Its Consolidated Net Income stands at $108.5 million for Q3 2025, versus -$144.1 million for Q4 2024 and -$66.9 million for Q3 2024.